For patients with ductal carcinoma in situ (DCIS), active monitoring (AM) is noninferior to guideline-concordant care (GCC) ...

The first study comparing surgery to active monitoring as treatment for ductal carcinoma in situ (DCIS) finds women who carefully monitor the precancerous cells are no more likely to develop breast ...

Researchers examined pooled data from two clinical trials that enrolled patients with low- or intermediate-grade ductal ...

The research, published in JAMA, suggests that active monitoring could be a viable alternative to surgery and radiation for low-risk patients with ductal carcinoma in situ (DCIS), known as stage zero ...

In this prespecified secondary analysis of the Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET ...

A "watch-and-wait" strategy might be the best option for some women with early-stage, low-risk breast cancer.

Two recent studies explore options for early-stage breast cancer patients to reduce surgery. One suggests active monitoring ...

Women with low-risk ductal carcinoma in situ randomized to active monitoring did not have a higher rate of invasive cancer in the ...

A new study, published in the New England Journal of Medicine, examines whether removing lymph nodes is always necessary in ...

Patients with low-risk ductal carcinoma in situ (DCIS) who underwent active monitoring reported comparable physical, emotional, and psychological outcomes to patients who received upfront treatment, ...

Research presented at the San Antonio Breast Cancer Symposium suggests women with early-stage breast cancer could safely ...